# TG Therapeutics, Inc. (TGTX) — Revenue

## Annual Revenue (USD)

| Year | Revenue |
| --- | --- |
| 2025 | $616M |
| 2024 | $329M |
| 2023 | $234M |
| 2022 | $3M |
| 2021 | $7M |
| 2020 | $152,000 |
| 2019 | $152,000 |
| 2018 | $152,000 |
| 2017 | $152,000 |
| 2016 | $152,000 |

## Quarterly Revenue (USD)

| Quarter | Revenue |
| --- | --- |
| 2026-03-31 | $205M |
| 2025-09-30 | $162M |
| 2025-06-30 | $141M |
| 2025-03-31 | $121M |
| 2024-09-30 | $84M |
| 2024-06-30 | $73M |
| 2024-03-31 | $63M |
| 2023-09-30 | $166M |
| 2023-06-30 | $16M |
| 2023-03-31 | $8M |
| 2022-09-30 | $94,000 |
| 2022-06-30 | $594,000 |
| 2022-03-31 | $2M |
| 2021-09-30 | $2M |
| 2021-06-30 | $2M |
| 2021-03-31 | $793,000 |
| 2020-09-30 | $38,000 |
| 2020-06-30 | $38,000 |
| 2020-03-31 | $38,000 |
| 2019-09-30 | $38,000 |
| 2019-06-30 | $38,000 |
| 2019-03-31 | $38,000 |
| 2018-09-30 | $38,000 |
| 2018-06-30 | $38,000 |

Source: [MarketCapTrends](https://marketcaptrends.com/company/TGTX/revenue)